Strategic Global Advisors, LLC

Position in AZN — Astrazeneca PLC

CIK 1580212 NEWPORT BEACH, CA

Position in AZN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,267,230

+$457,840 QoQ

Shares Held

6,683

+62.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.18%

of 13F equity value

Holder Rank

#617

of 1,462 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 87% Shared 0% None 13%

Healthcare · as of Jun 30, 2026

Strategic Global Advisors, LLC holds $15,490,781 across 5 Drug Manufacturers - General names. AZN ranks #5 (8.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	28,920	$7,277,428
2	NVS	Novartis AG	17,342	$2,717,838
3	GILD	Gilead Sciences, Inc.	17,586	$2,221,815
4	SNY	Sanofi	47,034	$2,006,470
5	AZN	Astrazeneca PLC This page	6,683	$1,267,230

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,267,230	6,683	+62.8%	Shares	Sole	2026-08-14
2026-03-31	$809,390	4,104	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.